Coverage of CYAB remains limited, so the consensus appears more uniform than it might otherwise be. Two current price targets stand out. ThinkEquity initiated coverage with a Buy rating and a $1.00 target in September 2026, pointing to revenue acceleration and gross margins above 80%. Maxim Group followed with a reiterated Buy rating and the same $1.00 target in August 2026. The calculated mean comes to $1.00, with a tight range of $1.00 to $1.00.
This narrow band stems more from sparse sell-side attention than from unified agreement across many firms. Investors should view the $1.00 figure as a shared outlook from two houses rather than a broad consensus. No other credible targets appear materially higher or lower at this time.
CYAB most recently closed near $0.099 and has moved in a tight band between roughly $0.08 and $0.12 in recent sessions. Reaching the $1.00 level from here would require upside of about 900%, a substantial move by any measure. The 52-week range of approximately $0.08 to $6.20, with an intraday peak near $14.91, highlights how sharply shares have fallen from earlier levels.
The route to $1.00 hinges on sustained growth and balance-sheet stability. At current prices the market capitalization sits at just a few million dollars, with trailing twelve-month revenue around $6.4 million and a TTM net loss of about $21.6 million.
Cyabra works in a growing segment focused on AI-driven narrative intelligence and disinformation detection for governments, media firms, and enterprises. Recent announcements include six-figure contracts with a major media company and a Southeast Asian national investigative agency, pointing to traction in key verticals.
Gross margins have stayed above 80%, and revenue rose roughly 37% in fiscal 2025. Analyst forecasts call for revenue to reach about $8.1 million in fiscal 2026 and $14.4 million in fiscal 2027, with losses per share expected to narrow. The small share count and thin float mean any positive development can trigger sizable percentage moves.
Significant hurdles remain. Cyabra continues to post losses, with a TTM net loss of roughly $21.6 million against cash of about $794,000 at the latest report. Negative free cash flow and a share count that has more than doubled year over year point to ongoing dilution.
Shareholders approved a discretionary 1-for-2 to 1-for-30 reverse stock split to help meet Nasdaq minimum-bid-price rules, underscoring the regulatory pressure from the sub-$1 price. A -99% one-year decline, limited liquidity, and reliance on smaller contract wins add to the risks. Any reverse split would alter the share price mechanically and shift the context around the $1.00 objective.
Technically, CYAB trades just above its 52-week low near $0.08, the nearest notable support. The stock sits well below both its 50-day and 200-day moving averages, confirming a strong downtrend. On the upside, $1.00 serves as both the analyst target and the Nasdaq bid-price threshold, creating an important resistance area. Earlier highs near $6.20 and $14.91 lie far above current levels and hold little relevance for near-term recovery prospects.
Analyst targets generally cover a 12-month horizon, and both reviewed targets align with that timeframe. The next estimated earnings release falls around late November 2026. Key items to watch include quarterly revenue trends, new contract wins, cash burn and liquidity, any reverse-split implementation, and progress toward Nasdaq compliance. Revisions from analysts, or the lack of them, will also matter given the limited coverage.
I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Tickeron's AI Daily Buy/Sell Signals apply artificial intelligence to track thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on evolving market conditions, technical patterns, and AI analysis. For a volatile, thinly traded name like CYAB, such tools can help flag momentum shifts and technical changes more efficiently than manual review alone.
The $1.00 target represents the average of two verified analyst estimates, both implying roughly 900% upside from the latest price. That remains a substantial required move and rests on a single shared thesis rather than extensive coverage. The positive case draws from high gross margins, rising demand for AI disinformation tools, and recent contract activity, while the risks center on ongoing losses, limited cash, dilution, and the planned reverse split. Reaching the target will depend on revenue execution, capital management, and Nasdaq compliance, none of which is assured. Investors should assess these elements against their own risk tolerance and follow the upcoming earnings report closely.
In my own process I often rely on Tickeron’s AI Daily Buy/Sell Signals to monitor momentum in names like this. The platform scans market data continuously and highlights potential shifts, which can be especially useful for tracking thinly traded stocks where manual charting takes extra time. It fits naturally into a broader research routine without replacing fundamental review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Indicator for CYAB moved out of oversold territory on November 11, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 13 similar instances when the indicator left oversold territory. In 9 of the 13 cases the stock moved higher. This puts the odds of a move higher at 69%.
The Moving Average Convergence Divergence (MACD) for CYAB just turned positive on October 20, 2026. Looking at past instances where CYAB's MACD turned positive, the stock continued to rise in 13 of 42 cases over the following month. The odds of a continued upward trend are 31%.
Following a +3.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where CYAB advanced for three days, in 32 of 86 cases, the price rose further within the following month. The odds of a continued upward trend are 37%.
CYAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYAB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Aroon Indicator for CYAB entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.130) is normal, around the industry mean (16.272). P/E Ratio (-0.061) is within average values for comparable stocks, (52.956). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.430) among similar stocks. P/S Ratio (0.671) is also within normal values, averaging (103.889).
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. CYAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications